Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Researchers propose a 10-component voucher plan for universal health coverage that aims to preserve patient choice and competition in the health care marketplace.